Financial News
Rocket Lab Successfully Launches 45th Electron Mission, 4th for Longtime Partner Synspective
Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today launched its 45th Electron rocket, successfully deploying a fourth synthetic aperture radar satellite to Synspective’s Earth-observation constellation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312332484/en/
Rocket Lab's 45th Electron mission, "Owl Night Long," lifted off from Launch Complex 1 in Mahia, New Zealand, carrying a satellite for Japanese Earth-observation company Synspective, on March 13 at 4:03 a.m. NZDT. (Photo credit: Rocket Lab)
“Owl Night Long,” a dedicated mission for Synspective, launched from Pad B at Rocket Lab’s Launch Complex 1 in New Zealand at 04:03 NZDT March 13, 2024 (15:03 UTC, March 12). The mission delivered a single spacecraft, the StriX-3 satellite, to a 561km Sun Synchronous Orbit, where it joined Synspective’s growing constellation.
Rocket Lab has been the sole launch provider for Synspective’s constellation, previously delivering three satellites across launches in September 2022, February 2022, and December 2020. Rocket Lab will launch two more missions for Synspective as part of a multi-launch agreement signed in 2023.
“Owl Night Long” was Rocket Lab’s third Electron mission of 2024. Rocket Lab’s next launch is scheduled to liftoff no earlier than March 20th from Launch Complex 2 in Wallops, Virginia for the National Reconnaissance Office.
Images and video from the launch of ‘Owl Night Long” are available for download here: https://flic.kr/s/aHBqjBhdGh
+ About Rocket Lab
Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufacture, spacecraft components, and on-orbit management solutions that make it faster, easier, and more affordable to access space. Headquartered in Long Beach, California, Rocket Lab designs and manufactures the Electron small orbital launch vehicle, the Photon satellite platform, and the Company is developing the large Neutron launch vehicle for constellation deployment. Since its first orbital launch in January 2018, Rocket Lab’s Electron launch vehicle has become the second most frequently launched U.S. rocket annually and has delivered 178 satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. Rocket Lab’s Photon spacecraft platform has been selected to support NASA missions to the Moon and Mars, as well as the first private commercial mission to Venus. Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a third launch pad in Virginia. To learn more, visit www.rocketlabusa.com.
+ About Synspective
Synspective, established in 2018, is an end-to-end SAR satellite data and solution provider with the mission to realize a learning world for people to expand their capabilities and make tangible progress with new data and technologies.
With a SAR satellite constellation that enables high-frequency and high-resolution Earth observation, Synspective delivers satellite data and various solutions that combine SAR and IoT data with machine learning and data science techniques.
+ Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development, operational expansion and business strategy are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the “SEC”), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at www.rocketlabusa.com, which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240312332484/en/
Contacts
+ Rocket Lab Media Contact
Morgan Bailey
media@rocketlabusa.com
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.